![](/sustainability/atm/improvingatm/images/index_img_mv.jpg)
Flexible Pricing Policy in Emerging and Developing Countries
In addition to the patient contribution through innovative new drug development and sales, Ӱҵhas established a core strategy consisted of affordable pricing, provision of disease solutions, public-private partnerships and local partnerships, to contribute to improving access to medicines in emerging and developing countries.
Flexible Pricing Policy in Emerging and Developing Countries
Approval Status of Global Products
Ӱҵstrives to bring products to many patients who need them all over the world. Please visit to see the approval status of Ӱҵglobal products in each country and region.
Approval Status of Global Products